Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
This depends on your individual health profile and current medications
GLP-3 (LY3437943) is an innovative investigational peptide developed by Eli Lilly that functions as a triple agonist of the GLP-1, GIP, and GCG receptorsalso referred to as a GGG triagonist
For patients with type 2 diabetes who are concerned about dementia risk, optimizing overall diabetes management remains the evidence-based priority
GLP-1 (glucagon-like peptide-1) is a naturally occurring hormone that regulates appetite and blood sugar
IVYour Concierge Support A licensed clinician, matched to you
Efruxifermin Efruxifermin, a bivalent Fc-FGF21 analog developed by Akero Therapeutics, functions as a balanced agonist of FGFR1c, FGFR2c, and FGFR3c through activation of the -Klotho co-receptor
US$ 22.17
US$ 22.30
US$ 26.43
US$ 25.10
